España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Akero Therapeutics
AKRO
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$55.36
1.36
2.52%
At close: -
$55.04
-0.32
-0.58%
After Hours: 4:11 PM EDT
Get Report
Comment
Akero Therapeutics (AKRO) Forecast
News
Earnings
Akero Therapeutics (AKRO) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Akero Therapeutics (NASDAQ:AKRO) Stock
Akero Therapeutics Stock (NASDAQ: AKRO)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, January 30, 2025
B of A Securities Upgrades Akero Therapeutics...
Benzinga Newsdesk
Wednesday, January 29, 2025
Reported Earlier, Akero Therapeutics Prices $...
Benzinga Newsdesk
Tuesday, January 28, 2025
9 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Morgan Stanley Maintains Overweight on Akero ...
Benzinga Newsdesk
Royal Caribbean Cruises Posts Upbeat Earnings, Joins Brighthouse Financial, Invesco, Boeing And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
McDonald's To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Tuesday
Avi Kapoor
Citigroup Maintains Buy on Akero Therapeutics...
Benzinga Newsdesk
Canaccord Genuity Maintains Buy on Akero Ther...
Benzinga Newsdesk
Monday, January 27, 2025
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Akero Therapeutics Commences Public Offering ...
Benzinga Newsdesk
S&P 500 Falls Over 100 Points; Dada Nexus Shares Spike Higher
Avi Kapoor
Dow Edges Higher; AT&T Posts Upbeat Earnings
Avi Kapoor
Dada Nexus, Titan Machinery, AT&T And Other Big Stocks Moving Higher On Monday
Avi Kapoor
Nasdaq Dips 3%; Chicago Fed National Activity Index Rises In December
Avi Kapoor
Liver Disease-Focused Akero Therapeutics Stock Soars Over 100% On Monday - Here's Why
Vandana Singh
Akero Therapeutics shares are trading higher ...
Benzinga Newsdesk
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Akero Therapeutics Released Preliminary Topli...
Benzinga Newsdesk
Friday, January 24, 2025
Akero To Announce SYMMETRY Study Phase 2b Res...
Benzinga Newsdesk
Thursday, January 16, 2025
HC Wainwright & Co. Reiterates Buy on Akero T...
Benzinga Newsdesk
Monday, January 13, 2025
Akero Therapeutics Said It Has Completed Enro...
Benzinga Newsdesk
Monday, November 18, 2024
Citigroup Initiates Coverage On Akero Therape...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Akero T...
Benzinga Newsdesk
Friday, November 15, 2024
Akero Therapeutics To Showcase New Analyses O...
Benzinga Newsdesk
Monday, November 11, 2024
HC Wainwright & Co. Reiterates Buy on Akero T...
Benzinga Newsdesk
Friday, November 08, 2024
Akero Therapeutics Q3 EPS $(1.05) Misses $(0....
Benzinga Newsdesk
Wednesday, October 30, 2024
Axonis Therapeutics Announced The Successful ...
Benzinga Newsdesk
Tuesday, September 17, 2024
HC Wainwright & Co. Reiterates Buy on Akero T...
Benzinga Newsdesk
Thursday, September 12, 2024
Oxford Industries Reports Weak Results, Joins Viper Energy And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Avi Kapoor
Monday, September 09, 2024
Akero Therapeutics Has Dosed The First Patien...
Benzinga Newsdesk
Monday, August 12, 2024
HC Wainwright & Co. Reiterates Buy on Akero T...
Benzinga Newsdesk
Friday, August 09, 2024
Akero Therapeutics Q2 EPS $(0.81) Beats $(0.9...
Benzinga Newsdesk
Thursday, August 08, 2024
Editas Q2 Earnings & Revenues Miss Estimates, Stock Down
Zacks
Monday, July 15, 2024
This Analyst Sees Potential Downside In Eli Lilly, Adjusts Model For Acquired IPR&D Charges
Shivani Kumaresan
Thursday, June 20, 2024
Cantor Fitzgerald Reiterates Overweight on Ak...
Benzinga Newsdesk
Wednesday, June 12, 2024
Cantor Fitzgerald Reiterates Overweight on Ak...
Benzinga Newsdesk
Tuesday, June 11, 2024
Wolfe Research Initiates Coverage On Akero Th...
Benzinga Newsdesk
Akero Therapeutics Begins Phase 3 Study on Ef...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Akero T...
Benzinga Newsdesk
Monday, June 10, 2024
Reported Saturday, Akero Therapeutics Present...
Benzinga Newsdesk
Wednesday, June 05, 2024
What's Going On With Fattly Liver Disease Focused Madrigal Pharmaceuticals, Sagimet Biosciences Shares On Wednesday?
Vandana Singh
Wednesday, May 15, 2024
Evercore ISI Group Maintains Outperform on Ak...
Benzinga Newsdesk
Monday, May 13, 2024
Canaccord Genuity Maintains Buy on Akero Ther...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Akero T...
Benzinga Newsdesk
Friday, May 10, 2024
Akero Therapeutics Q1 EPS $(0.90) Beats $(0.9...
Benzinga Newsdesk
Monday, April 22, 2024
B of A Securities Reinstates Neutral on Akero...
Benzinga Newsdesk
Thursday, March 07, 2024
Akero Therapeutics Publishes Phase 2b SYMMETR...
Benzinga Newsdesk
Wednesday, March 06, 2024
Akero Therapeutics Prices Public Offering Of ...
Benzinga Newsdesk
Tuesday, March 05, 2024
Akero Therapeutics shares are trading lower a...
Benzinga Newsdesk
UBS Maintains Buy on Akero Therapeutics, Rais...
Benzinga Newsdesk
Show More